SERNOVA Trademark

Trademark Overview

On Thursday, June 12, 2025, a trademark application was filed for SERNOVA with the United States Patent and Trademark Office. The USPTO has given the SERNOVA trademark a serial number of 99230815. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 12, 2025. This trademark is owned by Sernova Biotherapeutics Inc.. The SERNOVA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Cells and biological tissues for medical use; implantable drug delivery devices filled with pharmaceutical preparations for use in the treatment of hypopituitarism, growth hormone deficiency, hypogonadism, Turner syndrome, primary ovarian insufficiency, menopause symptoms, thyroid disease, hypoparathyroidism, neutropenia, hemophilia, adrenal insufficiency, diabetes, hepatic cirrhosis, and renal-induced anemia

Implantable biohybrid organ devices that combine living cells and tissue with synthetic materials to support, replace, or restore organ or tissue function for use in cell therapy; implants consisting of artificial materials
sernova

General Information

Serial Number99230815
Word MarkSERNOVA
Filing DateThursday, June 12, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCells and biological tissues for medical use; implantable drug delivery devices filled with pharmaceutical preparations for use in the treatment of hypopituitarism, growth hormone deficiency, hypogonadism, Turner syndrome, primary ovarian insufficiency, menopause symptoms, thyroid disease, hypoparathyroidism, neutropenia, hemophilia, adrenal insufficiency, diabetes, hepatic cirrhosis, and renal-induced anemia
Goods and ServicesImplantable biohybrid organ devices that combine living cells and tissue with synthetic materials to support, replace, or restore organ or tissue function for use in cell therapy; implants consisting of artificial materials

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 12, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSernova Biotherapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVancouver, BC V6E 4N7

Trademark Events

Event DateEvent Description
Thursday, June 12, 2025NEW APPLICATION ENTERED
Thursday, June 12, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

sernova materials tissue organ insufficiency devices implantable cells biohybrid diabetes adrenal